414 related articles for article (PubMed ID: 17827457)
1. Pharmacologic approaches to radiation protection.
Brizel DM
J Clin Oncol; 2007 Sep; 25(26):4084-9. PubMed ID: 17827457
[TBL] [Abstract][Full Text] [Related]
2. Future strategies for mitigation and treatment of chronic radiation-induced normal tissue injury.
Moulder JE; Cohen EP
Semin Radiat Oncol; 2007 Apr; 17(2):141-8. PubMed ID: 17395044
[TBL] [Abstract][Full Text] [Related]
3. The role of amifostine as a radioprotector.
Wasserman TH; Brizel DM
Oncology (Williston Park); 2001 Oct; 15(10):1349-54; discussion 1357-60. PubMed ID: 11702962
[TBL] [Abstract][Full Text] [Related]
4. Radiation-induced toxicities: the role of radioprotectants.
Curran WJ
Semin Radiat Oncol; 1998 Oct; 8(4 Suppl 1):2-4. PubMed ID: 9794993
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological strategies to spare normal tissues from radiation damage: useless or overlooked therapeutics?
Bourgier C; Levy A; Vozenin MC; Deutsch E
Cancer Metastasis Rev; 2012 Dec; 31(3-4):699-712. PubMed ID: 22706781
[TBL] [Abstract][Full Text] [Related]
6. Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology.
Bentzen SM
Nat Rev Cancer; 2006 Sep; 6(9):702-13. PubMed ID: 16929324
[TBL] [Abstract][Full Text] [Related]
7. [Modern possibilities of medicinal prophylaxis and early therapy of radiation injuries].
Grebeniuk AN; Zatsepin VV; Nazarov VB; Vlasenko TN
Voen Med Zh; 2011 Feb; 332(2):13-7. PubMed ID: 21770338
[TBL] [Abstract][Full Text] [Related]
8. Cytoprotection for radiation-associated normal tissue injury.
Mao J; Fatunase OA; Marks LB
Cancer Treat Res; 2008; 139():307-27. PubMed ID: 18236722
[No Abstract] [Full Text] [Related]
9. Radioprotective agents for radiation therapy: future trends.
Johnke RM; Sattler JA; Allison RR
Future Oncol; 2014 Dec; 10(15):2345-57. PubMed ID: 25525844
[TBL] [Abstract][Full Text] [Related]
10. Amifostine: the first selective-target and broad-spectrum radioprotector.
Kouvaris JR; Kouloulias VE; Vlahos LJ
Oncologist; 2007 Jun; 12(6):738-47. PubMed ID: 17602063
[TBL] [Abstract][Full Text] [Related]
11. Prevention and management of radiation myelopathy.
Ang KK; Stephens LC
Oncology (Williston Park); 1994 Nov; 8(11):71-6; discussion 78, 81-2. PubMed ID: 7826840
[TBL] [Abstract][Full Text] [Related]
12. Improving the morbidity of anorectal injury from pelvic radiotherapy.
Abbasakoor F; Vaizey CJ; Boulos PB
Colorectal Dis; 2006 Jan; 8(1):2-10. PubMed ID: 16519631
[TBL] [Abstract][Full Text] [Related]
13. Radioprotective effects of amifostine on acute and chronic esophageal injury in rodents.
Vujaskovic Z; Thrasher BA; Jackson IL; Brizel MB; Brizel DM
Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):534-40. PubMed ID: 17869666
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological management of acute radiation morbidity.
Zimmermann JS; Kimmig B
Strahlenther Onkol; 1998 Nov; 174 Suppl 3():62-5. PubMed ID: 9830460
[TBL] [Abstract][Full Text] [Related]
15. Radioprotectors: current status and new directions.
Grdina DJ; Murley JS; Kataoka Y; Zhou D; Seed TM
Radiat Res; 2005 Jun; 163(6):704-5. PubMed ID: 16044505
[No Abstract] [Full Text] [Related]
16. Radioprotective countermeasures for radiation injury (Review).
Liu L; Liang Z; Ma S; Li L; Liu X
Mol Med Rep; 2023 Mar; 27(3):. PubMed ID: 36799170
[TBL] [Abstract][Full Text] [Related]
17. Combined treatment with cytoprotective agents and radiotherapy.
Winczura P; Jassem J
Cancer Treat Rev; 2010 May; 36(3):268-75. PubMed ID: 20044209
[TBL] [Abstract][Full Text] [Related]
18. Radioprotection of craniofacial bone growth.
Gevorgyan A; La Scala GC; Neligan PC; Pang CY; Forrest CR
J Craniofac Surg; 2007 Sep; 18(5):995-1000. PubMed ID: 17912071
[TBL] [Abstract][Full Text] [Related]
19. Appraisal of mechanisms of radioprotection and therapeutic approaches of radiation countermeasures.
Mishra KN; Moftah BA; Alsbeih GA
Biomed Pharmacother; 2018 Oct; 106():610-617. PubMed ID: 29990850
[TBL] [Abstract][Full Text] [Related]
20. Amelioration of the pathological changes induced by radiotherapy in normal tissues.
Rezvani M
J Pharm Pharmacol; 2008 Aug; 60(8):1037-48. PubMed ID: 18644196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
